Long-term therapy with orally administered collagen peptides leads to an improvement of cellulite.
Cellulite is a complex problem that affects about 85% of women over the age of 20. It occurs mainly on the thighs, buttocks, and abdomen and is characterized by orange peel or cottage cheese appearance.
Factors linked to cellulite include genetics, gender, age, ethnicity, diet, sedentary lifestyle, and pregnancy. It is characterised by the presence of excess subcutaneous fat that bulges into the dermis, blood, and lymphatic disturbances and altered dermal extracellular matrix.
Although cellulite is often present in healthy individuals of normal weight, it is exacerbated by being overweight.
It is known that the improvements of dermal strength and skin elasticity are two important therapeutic aims in cellulite treatment. An oral therapy with bioactive collagen peptides is based on the premise that specific collagen peptides can improve and increase dermal firmness and skin elasticity from the inside.
In a double-blind, placebo-controlled clinical study, the efficacy of bioactive collagen peptides on the cellulite treatment of normal and overweight women was investigated.
The results of the study demonstrated that a regular ingestion of collagen peptides over a period of 6 months led to a clear improvement of the skin appearance in women suffering from moderate cellulite. Based on the current data, it can be concluded that a long-term therapy with orally administered collagen peptides leads to an improvement of cellulite and has a positive impact on skin health.
Reference:
Schunck, M. et al. (2015). Dietary Supplementation with Specific Collagen Peptides Has a Body Mass Index-Dependent Beneficial Effect on Cellulite Morphology. Journal of Medicinal Food, vol. 18, pp. 1340–1348.
